{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:16:05Z","timestamp":1789859765406,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1038\/sj.leu.2401704","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:29:24Z","timestamp":1031164164000},"page":"356-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials"],"prefix":"10.1038","volume":"14","author":[{"given":"I","family":"Hann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lilleyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OB","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the UK Medical Research Council's Working Party on Childhood Leukaemia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,3,7]]},"reference":[{"key":"BF2401704_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00043426-199801000-00001","volume":"20","author":"JE Rubnitz","year":"1998","unstructured":"Rubnitz JE, Look AT . Molecular genetics of childhood leukemias J Pediatr Hematol Oncol 1998 20: 1\u201311","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF2401704_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2141.1997.3493163.x","volume":"99","author":"JM Chessells","year":"1997","unstructured":"Chessells JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM . Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia Br J Haematol 1997 99: 93\u2013100","journal-title":"Br J Haematol"},{"key":"BF2401704_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","volume":"343","author":"MJ Brisco","year":"1994","unstructured":"Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H . Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction Lancet 1994 343: 196\u2013200","journal-title":"Lancet"},{"key":"BF2401704_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten Bosch, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2013Childhood Leukemia Cooperative Group New Engl J Med 1998 339: 591\u2013598","journal-title":"New Engl J Med"},{"key":"BF2401704_CR5","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJ van Dongen","year":"1998","unstructured":"van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 1998 352: 1731\u20131738","journal-title":"Lancet"},{"key":"BF2401704_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0950-3536(05)80208-2","volume":"7","author":"J Ochs","year":"1994","unstructured":"Ochs J, Mulhern R . Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia Bailli\u00e8res Clin Haematol 1994 7: 365\u2013376","journal-title":"Bailli\u00e8res Clin Haematol"},{"key":"BF2401704_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.1995.tb03313.x","volume":"89","author":"JM Chessells","year":"1995","unstructured":"Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB . Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials Br J Haematol 1995 89: 364\u2013372","journal-title":"Br J Haematol"},{"key":"BF2401704_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.leu.2400959","volume":"12","author":"JM Chessells","year":"1998","unstructured":"Chessells JM, Hall E, Prentice HG, Durrant J, Bailey CC, Richards SM . The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties Leukemia 1998 12: 463\u2013473","journal-title":"Leukemia"},{"key":"BF2401704_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00062752-199807000-00009","volume":"5","author":"CH Pui","year":"1998","unstructured":"Pui CH . Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia Curr Opin Hematol 1998 5: 292\u2013301","journal-title":"Curr Opin Hematol"},{"key":"BF2401704_CR10","unstructured":"Hutchinson RJ, Neerhout S, Bertolone S, Cooper HA, Roskos R, Tannous R, Wells L, Heerema N, Hummell D, Sailoer S, Sather H, Trigg M and the Children's Cancer Study Group . Should therapy be intensified for patients with good risk acute lymphoblastic leukaemia Am Soc Hematol 1996 A2662"},{"key":"BF2401704_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","volume":"329","author":"GK Rivera","year":"1993","unstructured":"Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM . Treatment of acute lymphoblastic leukemia. 30 years\u2019 experience at St Jude Children's Research Hospital New Engl J Med 1993 329: 1289\u20131295","journal-title":"New Engl J Med"},{"key":"BF2401704_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1200\/JCO.1993.11.3.520","volume":"11","author":"DG Tubergen","year":"1993","unstructured":"Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD . Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial J Clin Oncol 1993 11: 520\u2013526","journal-title":"J Clin Oncol"},{"key":"BF2401704_CR13","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122\u20133133","journal-title":"Blood"},{"key":"BF2401704_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","volume":"345","author":"JM Chessells","year":"1995","unstructured":"Chessells JM, Bailey C, Richards SM . Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia Lancet 1995 345: 143\u2013148","journal-title":"Lancet"},{"key":"BF2401704_CR15","first-page":"398a","volume":"92","author":"F Hill","year":"1998","unstructured":"Hill F, Hann I, Gibson B, Eden OB, Richards S . Comparison of high dose methotrexate with continuing intrathecal methotrexate versus intrathecal methotrexate alone in low white blood count childhood acute lymphoblastic leukaemia: preliminary results from the UKALLXI randomised trial Blood 1998 92: (Suppl. 1) 398a","journal-title":"Blood"},{"key":"BF2401704_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/bjc.1978.124","volume":"37","author":"SJ White","year":"1978","unstructured":"White SJ, Freedman LS . Allocation of patients to treatment groups in a controlled clinical study Br J Cancer 1978 37: 849\u2013857","journal-title":"Br J Cancer"},{"key":"BF2401704_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples Br J Cancer 1977 35: 1\u201339","journal-title":"Br J Cancer"},{"key":"BF2401704_CR18","first-page":"1","volume":"339","author":"Group Early Breast Cancer Trialists\u2019 Coll","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group . Systemic treatment of early breast cancer by hormonal cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24000 deaths among 75000 women Lancet 1992 339: 1\u201315","journal-title":"Lancet"},{"key":"BF2401704_CR19","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/1097-0142(19910515)67:10<2428::AID-CNCR2820671004>3.0.CO;2-J","volume":"67","author":"D Cox","year":"1991","unstructured":"Cox D . The contribution of statistical methods to cancer research Cancer 1991 67: 2428\u20132430","journal-title":"Cancer"},{"key":"BF2401704_CR20","unstructured":"SAS\/STAT User's Guide SAS Institute Inc: Cary, NC 1989"},{"key":"BF2401704_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<600::AID-CNCR24>3.0.CO;2-4","volume":"82","author":"PG Steinherz","year":"1998","unstructured":"Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN Trigg ME, Uckun FM, Bleyer WA . Treatment of patients with acute lymphoblastic leukemia with bulky extra-medullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group Cancer 1998 82: 600\u2013612","journal-title":"Cancer"},{"key":"BF2401704_CR22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","volume":"338","author":"JB Nachman","year":"1998","unstructured":"Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS . Augmented post-induction therapy for children with high-risk acute lymphoblastic leukaemia and a slow response to initial therapy New Engl J Med 1998 338: 1663\u20131671","journal-title":"New Engl J Med"},{"key":"BF2401704_CR23","first-page":"559a","volume":"90: Suppl. 1","author":"B Lange","year":"1997","unstructured":"Lange B, Sather H, Weetman R, Bostrom B, McGuire P, Rackoff W, Arthur D, Trigg M for the Children's Cancer Group . Double delayed intensification improves outcome in moderate risk paediatric acute lymphoblastic leukaemia \u2013 CCG 1891 study ASH 1997 90: Suppl. 1: 559a","journal-title":"ASH"},{"key":"BF2401704_CR24","first-page":"483","volume":"33","author":"G Henze","year":"1990","unstructured":"Henze G, Fengler R, Reiter A, Ritter J, Riehm H . Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia Hamatol Bluttransfus 1990 33: 483\u2013488","journal-title":"Hamatol Bluttransfus"},{"key":"BF2401704_CR25","first-page":"627","volume":"339","author":"A Morley","year":"1998","unstructured":"Morley A . Quantifying leukemia Lancet 1998 339: 627\u2013629","journal-title":"Lancet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401704","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:21:39Z","timestamp":1648758099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3,1]]}},"alternative-id":["BF2401704"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401704","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]},"assertion":[{"value":"2 September 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}